Last edition
News about "Aditi Panandikar"
Indoco Remedies Reports Improved Q1 FY27 Revenue and EBITDA
Indoco Remedies reported higher revenue and improved EBITDA in Q1 FY27, supported by the strong performance of its domestic formulations business and steady progress in international formulations and APIs.
Aditi Panandikar | 28/07/2026 | By News Bureau
Indoco Remedies Transfers Ophthalmic Division to Sunways India
Indoco Remedies transfers its ophthalmic business in India and select African markets to Sunways India under a strategic business transfer agreement to strengthen portfolio focus and growth.
Aditi Panandikar | 02/05/2026 | By News Bureau | 408
Indoco Receives USFDA EIR for Patalganga API Manufacturing Facility
Indoco has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration for its API manufacturing facility at Patalganga following an inspection conducted in the month of September.
Aditi Panandikar | 15/12/2025 | By News Bureau | 167
USFDA Completes Inspection of Indoco API Plant in Patalganga with Zero Observations
The inspection of Indoco’s API manufacturing facility at Patalganga by the US FDA concluded with zero form 483 observations.
Aditi Panandikar | 22/09/2025 | By Dineshwori | 232
Indoco Remedies Ltd. has received EU GMP certification from the European Health Authorities for its sterile drug manufacturing facility located in South Goa – Goa Plant II.
Aditi Panandikar | 24/07/2025 | By Mrinmoy Dey | 376
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy